|
Market Closed -
Nasdaq
16:00:00 2026-10-27 EDT
|
5-day change | 1st Jan Change | ||
| 4.160 USD | +1.96% |
|
+0.24% | +45.96% |
| 09-20 | Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to S&P Global BMI Index | CI |
| 08-31 | Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO | MT |
Stock exchange
Nasdaq
ORMP 4.160 $
+1.96%
404K
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ORMP | 4.160USD | +1.96% | 404K $ | ||
CBOE
| ORMP | 4.155USD | +2.34% | 25.55K $ | |
|
Börse Stuttgart
| OJU1 | 3.690EUR | +1.93% | 22.14K € | |
|
TEL AVIV STOCK EXCHANGE
| ORMP | 1,284.00ILa | -0.62% | 1.67M ILa | |
|
Tradegate
| OJU1 | 3.730EUR | +2.33% | 104.44 € | |
|
Deutsche Boerse AG
| OJU1 | 3.610EUR | +0.42% | 0 € | |
|
Boerse Muenchen
| OJU1 | 3.705EUR | +1.09% | 0 € |
Quotes 5-day view: Oramed Pharmaceuticals Inc.
Delayed Quote Nasdaq
| 2026-10-21 | 2026-10-22 | 2026-10-23 | 2026-10-26 | 2026-10-27 | |
|---|---|---|---|---|---|
| Last | US$4.140 | US$4.120 | US$4.130 | US$4.080 | US$4.160 |
| Volume | 84,413 | 97,615 | 115,662 | 109,118 | 97,228 |
| Change | -0.24% | -0.48% | +0.24% | -1.21% | +1.96% |
| Opening | US$4.160 | US$4.090 | US$4.100 | US$4.140 | US$4.100 |
| High | US$4.210 | US$4.210 | US$4.170 | US$4.200 | US$4.170 |
| Low | US$4.060 | US$4.075 | US$4.060 | US$4.040 | US$4.050 |
Performance
| 1 day | +1.96% | ||
| 1 week | +0.24% | ||
| Current month | -10.92% | ||
| 1 month | -12.05% | ||
| 6 months | +1.22% | ||
| Current year | +45.96% | ||
| 1 year | +75.53% | ||
| 3 years | +124.86% | ||
| 5 years | -81.89% | ||
| 10 years | -38.28% |
Volumes
marketsDaily volume
97,229
Estimated daily volume
97,229
Avg. Volume 20 sessions
132,777
Daily volume ratio
0.73
Avg. Volume 20 sessions USD
552,352.32
Record volume 1
28,551,520
Record volume 2
24,841,760
Record volume 3
17,091,290
Capital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
169,717,204
Net sales (USD)
2,000,000
Number of employees
4
Sales / Employee (USD)
500,000
Free-Float
78.73%
Free-Float capitalization (USD)
133,616,813
Average Daily Capital Traded
0.33%
Indicators
Moving average 5 days
4.126
Moving average 20 days
4.284
Moving average 50 days
4.615
Moving average 100 days
4.39
Price spread / (MMA5)
-0.82%
Price spread / (MMA20)
+2.97%
Price spread / (MMA50)
+10.93%
Price spread / (MMA100)
+5.53%
STIM
RSI 9 days
31.82
RSI 14 days
34.31
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.96% | +0.24% | +75.53% | +124.86% | 170M | |
| -3.10% | -4.19% | +32.67% | +59.47% | 65.28B | |
| +0.33% | +0.33% | +10.16% | +78.07% | 54.57B | |
| +0.16% | +1.73% | +9.89% | +102.10% | 53.59B | |
| -0.75% | +1.38% | +24.89% | +50.91% | 45.03B | |
| -1.30% | -4.80% | +16.05% | +114.76% | 42.17B | |
| +1.26% | -5.26% | +221.12% | +900.64% | 39.42B | |
| -0.74% | -4.46% | +11.00% | +44.65% | 32.71B | |
| +1.75% | -8.10% | +23.50% | -10.10% | 24.01B | |
| +1.11% | +15.18% | +60.27% | +49.33% | 26.5B | |
| Average | +0.06% | -0.13% | +48.51% | +151.47% | 38.34B | |
| Weighted average by Cap. | -0.44% | -0.58% | +42.42% | +153.33% |
Historical Quotes: Oramed Pharmaceuticals Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Latest transactions
f0ea61e8fc1b561c.D4ht9_xZksAo3PJR2ZGKJyoTZC2KigN4m_E_ZKboqF4.Obg4gJ4Qyrgag4g1t6njUkVbCRT5uEYqzaBFDpakmDlGxSyNpRfAohyTgQ
| Date | Price | Volume | Total |
|---|---|---|---|
| 16:00:00 | 4.160 | 15,121 | 64,878 |
| 15:59:57 | 4.150 | 296 | 49,757 |
| 15:59:57 | 4.150 | 200 | 49,461 |
| 15:59:52 | 4.160 | 126 | 49,261 |
| 15:59:52 | 4.160 | 251 | 49,135 |
| 15:59:52 | 4.155 | 100 | 48,884 |
| 15:59:52 | 4.160 | 200 | 48,784 |
| 15:59:50 | 4.150 | 141 | 48,584 |
| 15:59:39 | 4.150 | 100 | 48,443 |
| 15:59:21 | 4.150 | 200 | 48,343 |
Price Extremes
| 1 week | 4.04 |  | 4.21 |
| 1 month | 3.89 | | 4.8 |
| Current year | 2.83 | | 5.47 |
| 1 year | 2.09 | | 5.47 |
| 3 years | 1.67 | | 5.47 |
| 5 years | 1.67 | | 31.54 |
| 10 years | 1.67 | | 31.54 |
Monthly variations
Annual variations
| 2026 | +45.96% | ||
| 2025 | +17.77% | ||
| 2024 | +4.76% | ||
| 2023 | -80.80% | ||
| 2022 | -15.76% | ||
| 2021 | +236.79% | ||
| 2020 | -17.67% | ||
| 2019 | +71.67% | ||
| 2018 | -66.67% | ||
| 2017 | +47.06% | ||
| 2016 | -28.42% | ||
| 2015 | +87.50% | ||
| 2014 | -70.45% | ||
| 2013 | +289.64% | ||
| 2012 | +17.86% | ||
| 2011 | -6.67% | ||
| 2010 | -33.33% | ||
| 2009 | +15.38% | ||
| 2008 | +50.00% | ||
| 2007 | -69.05% | ||
| 2006 | +170.97% | ||
| 2005 | +24.00% | ||
| 2004 | +1,549.94% |
- Stock Market
- Stocks
- ORMP Stock
- Quotes Oramed Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
